Gene Therapy Hope for Huntington's Disease
UK doctors have announced a significant breakthrough in treating Huntington's disease with the new gene therapy AMT-130, which demonstrated an impressive 75 percent slowing of disease progression in early-stage clinical trials. This groundbreaking development offers substantial hope for patients by targeting the root cause of the devastating neurodegenerative disorder, potentially ushering in a new era of treatment.